Funding will expand the range of Dualase® genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /PRNewswire/ - Specific Biologics Inc. ("Specific"), a biotechnology company developing industry-leading in vivo genome editing medicines to treat...
Hence then, the article about genome canada and ontario genomics award specific biologics and western university 1 8 million grant to develop a machine learning platform to accelerate the development of the company s dualase based therapeutics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Genome Canada and Ontario Genomics Award Specific Biologics and Western University $1.8 Million Grant to Develop a Machine Learning Platform to Accelerate the Development of the Company's Dualase®-based Therapeutics )
Also on site :
- Clarks’ ‘Incredibly Comfortable’ Leather Ballet Flats With Great Arch Support Are 44% Off at Macy’s
- Jack Dorsey became Twitter’s CEO when it launched in 2007; 13 years later, he pledged $1 billion of his fortune to pandemic relief
- ‘Merry Berry Love’ Producers Nippon TV & CJ ENM Talk Korea-Japan Collaboration To Boost J-Drama – TIFFCOM